TORONTO–(BUSINESS WIRE)–Tilray, a federally licensed producer of medical cannabis , announced today that it has signed a binding letter of intent (LOI) to be the exclusive collaborator of a major pharmaceutical company to accelerate innovation and increase availability of high quality medical … Read More
The post Tilray to Partner with Novartis Division Sandoz to Develop Medical Cannabis Products appeared first on Dagga Magazine.